Score Breakdown
Offering Ability
46
Cash Runway
65
Float Risk
57
Warrant Exposure
40
Convertible Debt
85
Dilution Forecast
⛈️
Warning
High probability of dilution event
model est. 53%
🔄 Reverse Split
model est. 65%
• 50-day avg $0.14 below $1 exchange minimum
• 10 months cash with weak price
🔁 Convertible Conversion
model 60%
• Major convertible overhang: 187% potential dilution
• Convertible risk score very high (85/100)
💰 Capital Raise
model 15%
• Under 12 months cash (10mo)
Market Data
Market Cap$2.67M
Shares Outstanding20.56M
Float9.28M
Cash$17.64M
Debt$38.09M
Short InterestN/A
Institutional Holdings
26.5% institutional ownership
Source: Yahoo Finance · Detailed 13F holder data available for tracked tickers
Short Interest
Short Interest144.5K
Days to Cover87.0
% of Float1.6%
FINRA data as of Jul 31, 2026
Recent SEC Activity
xbrl
XBRL CONVERTIBLE
2025-12-31
Full SEC filing analysis available with free account →
Recent News
No recent news
Factual CASIF Dilution Snapshot
CASI Pharmaceuticals, Inc. (CASIF) has a DilutionScore of 58/100, rated High dilution risk. Score date: August 28, 2026.
- Recent SEC activity tracked for CASIF: xbrl on 2025-12-31.
This automatically generated snapshot is assembled from stored DilutionWatch data fields and may contain data-source errors or omissions. It is not financial advice, not investment research, and not a recommendation. Do your own research and review the full disclaimer and terms of service.
Related Stocks — HIGH Risk
Other HIGH dilution risk stocks tracked by DilutionWatch with similar profiles: